KATIE JARSTAD: Open Payments
NPI 1326099672 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,218 in 90 payments from 20 companies in 2025. Trend: 2023 $987 · 2024 $1,183 · 2025 $1,218
Food & beverage: $1,218
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $250 |
| PFIZER INC. | 19 | $200 |
| GlaxoSmithKline, LLC. | 22 | $164 |
| Novo Nordisk Inc | 5 | $92 |
| Abbott Laboratories | 2 | $77 |
| Phathom Pharmaceuticals, Inc. | 10 | $73 |
| Edwards Lifesciences Corporation | 2 | $50 |
| Boston Scientific Corporation | 1 | $39 |
| Amgen Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $29 |
Products named: TRELEGY ELLIPTA, UBRELVY, QULIPTA, NURTEC ODT, VOQUEZNA, AMPLATZER AMULET, ELIQUIS, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV).
Industry payments across ID — which companies pay providers there.
